32 Results for "

antipsychotic compound

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "antipsychotic compound" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B1693
CAS No.: 60-99-1
Synonyms: Methotrimeprazine
Levomepromazine (Methotrimeprazine) is an orally active antipsychotic compound and Ca 2+ release inducer. Levomepromazine inhibits SERCA pump and induces an increase in cytoplasmic Ca 2+ levels. Levomepromazine has antagonistic effects on a variety of neurotransmitter receptors, including dopamine, cholinergic, serotonin, and histamine receptors. Levomepromazine can induce adaptive ER stress and autophagy. In addition, Levomepromazine has antiviral, anti-inflammatory, neuroprotective and analgesic, sedative and anti-injurious activities. Levomepromazine can be used in the study psychiatric disorders and relieving nausea and vomiting .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W344044
CAS No.: 7104-38-3
Synonyms: Methotrimeprazine maleate
Levomepromazine maleate (Methotrimeprazine maleate) is an orally active antipsychotic compound and Ca 2+ release inducer. Levomepromazine maleate inhibits SERCA pump and induces an increase in cytoplasmic Ca 2+ levels. Levomepromazine maleate has antagonistic effects on a variety of neurotransmitter receptors, including dopamine, cholinergic, serotonin, and histamine receptors. Levomepromazine maleate can induce adaptive ER stress and autophagy. In addition, Levomepromazine maleate has antiviral, anti-inflammatory, neuroprotective and analgesic, sedative and anti-injurious activities. Levomepromazine maleate can be used in the study psychiatric disorders and relieving nausea and vomiting .
loading...
    loading...
Cat. No.: HY-119393
CAS No.: 174794-02-6
Purity:  98.02%
Target:  

Others

Research Areas:  

Neurological Disease

Olanzapine N-oxide is a phase I metabolite of Olanzapine (HY-14541). Olanzapine N-oxide serves as a substrate for reduction reactions and converts to Olanzapine in whole blood in vitro. Olanzapine is an antipsychotic compound widely used in research on schizophrenia and other psychotic disorders .
loading...
    loading...
Cat. No.: HY-121002
CAS No.: 642-18-2
Alstonine is a major indole alkaloid compound of a plant-based remedy. Alstonine has antipsychotic, anxiolytic, anticancer and antimalarial properties .
loading...
    loading...
Cat. No.: HY-A0163A
CAS No.: 982-24-1
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Clopenthixol is a thiaquinoline compound with inhibitory effects similar to those of phenothiazine antipsychotics. Clopenthixol is an antagonist of D1 and D2 dopamine receptors. Clopenthixol is mainly used to suppress schizophrenia and other mental disorders .
loading...
    loading...
Cat. No.: HY-14458
CAS No.: 1228244-79-8
Research Areas:  

Neurological Disease

SCH-1518291 (Compound 27) is an orally active PDE10A inhibitor. SCH-1518291 exhibits antipsychotic activity in an ADHD rat model. SCH-1518291 can be used in research on neurological disorders such as psychosis .
loading...
    loading...
Cat. No.: HY-W131122
CAS No.: 288-99-3
Target:  

Bacterial

Research Areas:  

Others

1,3,4-Oxadiazoles are a class of synthetic compounds with important medicinal value, which show a variety of biological activities such as anticonvulsant, antidepressant, analgesic, anti-inflammatory, antiallergic, antipsychotic, antimicrobial, antituberculous, antitumor, and antiviral. 1,3,4-Oxadiazole derivatives need to be further developed .
loading...
    loading...
Cat. No.: HY-34763
CAS No.: 70500-72-0
Synonyms: 7-Hydroxyquinolinone; 2,7-Dihydroxyquinoline
Target:  

Drug Derivative

Research Areas:  

Others

7-Hydroxycarbostyril (7-Hydroxy-2(1H)-quinolinone) (Compound 7) is a quinolinone derivative. 7-Hydroxycarbostyril can be used for synthesis of Brexpiprazole (HY-15780). Brexpiprazole, a typical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor .
loading...
    loading...
Cat. No.: HY-B1693A
CAS No.: 1236-99-3
Synonyms: Methotrimeprazine hydrochloride
Levomepromazine (Methotrimeprazine) hydrochloride is an orally active antipsychotic compound and Ca 2+ release inducer. Levomepromazine inhibits SERCA pump and induces an increase in cytoplasmic Ca 2+ levels. Levomepromazine hydrochloride has antagonistic effects on a variety of neurotransmitter receptors, including dopamine, cholinergic, serotonin, and histamine receptors. Levomepromazine hydrochloride can induce adaptive ER stress and autophagy. In addition, Levomepromazine hydrochloride has antiviral, anti-inflammatory, neuroprotective and analgesic, sedative and anti-injurious activities. Levomepromazine hydrochloride can be used in the study psychiatric disorders and relieving nausea and vomiting .
loading...
    loading...
Cat. No.: HY-156532C
CAS No.: 2104810-16-2
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

(-)-5-HT2C agonist-3 (compound (-)-19) is a 5-HT2C selective agonist with Gq signaling preference, with EC50 values for 5-HT2 receptors of 5-HT2C: 103 nM; 5-HT2B: 570 nM; 5-HT2A: 72 nM. (-)-5-HT2C agonist-3 can be used in antipsychotic research .
loading...
    loading...
Cat. No.: HY-B1693R
CAS No.: 60-99-1
Synonyms: Methotrimeprazine (Standard)
Levomepromazine (Standard) is the analytical standard of Levomepromazine. This product is intended for research and analytical applications. Levomepromazine (Methotrimeprazine) is an orally active antipsychotic compound and Ca 2+ release inducer. Levomepromazine inhibits SERCA pump and induces an increase in cytoplasmic Ca 2+ levels. Levomepromazine has antagonistic effects on a variety of neurotransmitter receptors, including dopamine, cholinergic, serotonin, and histamine receptors. Levomepromazine can induce adaptive ER stress and autophagy. In addition, Levomepromazine has antiviral, anti-inflammatory, neuroprotective and analgesic, sedative and anti-injurious activities. Levomepromazine can be used in the study psychiatric disorders and relieving nausea and vomiting .
loading...
    loading...
Cat. No.: HY-114682A
CAS No.: 24677-86-9
Synonyms: AHR 2277
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Lenperone hydrochloride (AHR 2277) is an antipsychotic compound and a dopamine antagonist. Lenperone hydrochloride reduces gastroesophageal sphincter pressure of healthy dogs. Lenperone hydrochloride can be used for neurological disease research .
loading...
    loading...
Cat. No.: HY-119183
CAS No.: 61955-05-3
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

A 23887 is a semirigid antipsychotic compound with considerable affinity for dopamine D2 receptor .
loading...
    loading...
Cat. No.: HY-149247
CAS No.: 3043786-44-0
Research Areas:  

Neurological Disease

Antipsychotic agent-2 (Compound 11) is a potent antipsychotic agent. Antipsychotic agent-2 shows affinities for 5-HT1A, 5-HT2A, 5-HT2C, D2 and H1 receptors with Kis of 56.6, 66.7, 552, 596 and 1140 nM, respectively. Antipsychotic agent-2 has BBB permeability .
loading...
    loading...
Cat. No.: HY-123139
CAS No.: 70801-02-4
Synonyms: CP-36584
Research Areas:  

Neurological Disease

Flutroline (CP-36584), a tetrahydro-7-carboline compound, is an orally active and potent anti-psychotic compound .
loading...
    loading...
Cat. No.: HY-147530
CAS No.: 2582758-47-0
Target:  

mGluR

Research Areas:  

Neurological Disease

mGluR2 modulator 4 (compound 47) is a potent mGluR2 positive allosteric modulator with an EC50 value of 0.8 μM. mGluR2 modulator 4 can be used for researching antipsychotic .
loading...
    loading...
Cat. No.: HY-117118A
CAS No.: 359878-19-6
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

AC-90179 is a selective 5-HT2A receptor inverse agonist (Ki = 2.1 nM) and 5-HT2C antagonist, a potential antipsychotic compound .
loading...
    loading...
Cat. No.: HY-144698
CAS No.: 1678501-16-0
Target:  

mGluR

Research Areas:  

Neurological Disease

mGlu4 receptor agonist 1 (compound 62) is a potent mGlu4 receptor positive allosteric modulator, with an EC50 of 308 nM. mGlu4 receptor agonist 1 shows significant anxiolytic- and antipsychotic-like effect .
loading...
    loading...
Cat. No.: HY-147528
CAS No.: 1004614-86-1
Target:  

mGluR

Research Areas:  

Neurological Disease

mGluR2 modulator 2 (compound 2) is a potent, selective and orally bioavailable mGluR2 positive allosteric modulator with an EC50 value of 0.13 μM. mGluR2 modulator 2 can be used for researching antipsychotic .
loading...
    loading...
Cat. No.: HY-106400
CAS No.: 494861-87-9
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

EGIS 11150 is a adrenergic reporter antagonist that has high affinity for adrenergic α1, α2c, 5-HT2A reporters. EGIS 11150 is an antipsychotic compound with procognitive efficacy .
loading...
    loading...